Prescription Drug Plan Sponsors Get Help Navigating Uncertain Times in Drug Pricing
Posted on: Wednesday, 9 January 2008, 18:00 CST
After more than a year since major lawsuits cast a dark shadow over the use of average wholesale price as a benchmark for prescription drug pricing, little change has taken place in the way of finding a suitable alternative for the AWP benchmark.
Brian Bullock, president and CEO of The Burchfield Group, is working with employers and other prescription drug plan providers to prepare for changes that will eventually come in the wake of AWP. The Burchfield Group is a pharmacy-benefit consulting firm that helps employers and other plan sponsors control the costs of providing prescription drug coverage for their beneficiaries. He sees pharmacy benefit managers working to change contract language in preparation for a replacement benchmark, but those changes might not be enough, according to Bullock.
Bullock and colleague Kent D. Wangsness, who holds a doctor of pharmacy degree and is a vice president at The Burchfield Group, discussed these issues and more in the today's installment of the Pharmacy Benefits Podcast, which can be found at www.burchfieldgroup.com. Bullock says the market has seen a number of options floated as alternatives to AWP -- including wholesale acquisition cost, average manufacturer price and average selling price -- but none seems to fit what Bullock calls the four essential criteria for a replacement pricing benchmark. According to Bullock, the replacement must be:
-- accurate and reliable -- current and up to date -- generally and widely available -- transparent and accessible
"It's important for employers to have a handle on what is going on in their prescription claims data, what the pricing looks like, and how are we going to equitably adjust for pricing with new contract terms," Bullock said. "Plan sponsors can end up upside down if contract language does not protect them in the event the prescription drug pricing benchmark changes. A plan sponsor can only make solid, learned decisions with access to substantial, transparent data and an understanding of the significance of the details."
For more ideas on how to handle potential changes in prescription drug pricing, or to ask a question or comment on the podcast, send an e-mail to Bullock at bbullock@burchfieldgroup.com or call 651-389-5640.
About The Burchfield Group
The Burchfield Group is a pharmacy benefit management consultancy based in St. Paul, Minn. The Burchfield Group brings innovative perspectives to managing pharmacy benefits, helping plan sponsors evaluate and select pharmacy benefit administration vendors, designing pharmacy benefit plans, monitoring plan and PBM performance, and auditing results. Their staff of experts has a vast knowledge of the PBM industry, including insight into drug manufacturers' influences, mail service profits and retail network margins. (www.burchfieldgroup.com)
Contact: Michael Keliher 651-695-0174 - office 651-324-0213 - cell mkeliher@providentpartners.net
SOURCE: Burchfield Group
Source: MARKET WIRE
Related Articles
- BMHC Reaches Agreement With Secured Lender Group on Plan to Restructure Balance Sheet
- PBM Industry Veterans Add to Drug-Cost Management Expertise at The Burchfield Group
- Sprint to Launch Domestic Unlimited Pricing Plan
- Health Alliance Plan Announces New Statewide Medigap Plans and Prescription Drug Plans for 2008
- Iridium(R) Satellite Announces New North American Pricing Plan
- Timber Firm, Conservation Groups Unveil Plan to Preserve Maine Forestland
- TiVo Announces New Pricing Plans
- Coalition Forms to Battle New England Opposition to New Electric Pricing Plan
- Huge Fall in Price of Drugs on Street
- ADHD Drug Prescriptions Vary by ZIP Code
 |
 |
User Comments (0)
RSS Feeds